About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Federal Reserve's Williams: The impact of tariffs should diminish by 2026.

2026-01-13

Federal Reserve's Williams: The impact of tariffs should diminish by 2026.

Other News
2026-01-12

EU Commissioner Kubilius: According to EU treaties, EU member states are obligated to provide assistance to Denmark in the event of military aggression.

EU Commissioner Kubilius: According to EU treaties, EU member states are obligated to provide assistance to Denmark in the event of military aggression.
2026-01-13

Individual Stock News 1. Blue Moon Group (06993.HK): Expects significant improvement in performance for 2025. 2. Longfor Group (00960.HK): Total contracted sales amounted to RMB 63.16 billion in 2025. 3. China Resources Land (01109.HK): Total cont

Individual Stock News 1. Blue Moon Group (06993.HK): Expects significant improvement in performance for 2025. 2. Longfor Group (00960.HK): Total contracted sales amounted to RMB 63.16 billion in 2025. 3. China Resources Land (01109.HK): Total contracted sales amounted to approximately RMB 233.6 billion in 2025, a decrease of 10.5% year-on-year. 4. GigaDevice (03986.HK): Hong Kong public offering was oversubscribed by 542.22 times, with net proceeds of approximately HKD 4.611 billion from the global offering. 5. Pou Sheng International (03813.HK): Total consolidated net operating income for 2025 was RMB 17.132 billion, a decrease of 7.2% year-on-year. 6. Dongfeng Motor Group (00489.HK): Total vehicle sales for 2025 were 1.8962 million units, an increase of approximately 0.01% year-on-year. 7. Yue Yuen Group (00551.HK): Net consolidated operating income for 2025 was US$8.031 billion, a decrease of 1.85% year-on-year. 8. Zhipu (02513.HK): The Company is not aware of any information that needs to be disclosed to avoid a false market in the Company's securities. 9. WuXi AppTec (02359.HK) issued a profit warning: Net profit attributable to shareholders for 2025 is expected to be approximately RMB 19.151 billion, an increase of approximately 102.65% year-on-year. 10. Hengrui Medicine (01276.HK): SHR-1826 for injection has been included in the Breakthrough Therapy Product List by the Center for Drug Evaluation. 11. Q Technology (01478.HK): Sales of mobile phone camera modules in December reached 43.08 million units, an increase of 13.2% month-on-month and 40.8% year-on-year. 12. Rongchang Bio (09995.HK): Signed an exclusive licensing agreement with AbbVie for RC148, which includes an upfront payment of US$650 million and milestone payments of up to US$4.95 billion.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD